Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View

Dr. Karine Tawagi

GU Oncology · UIC

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    EADr. Emmanuel Antonarakis

    Dr. Emmanuel Antonarakis

    Hematology & Oncology · Genitourinary Oncology
    University of Minnesota
    emmanuela

    Research

    Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study

    2026

    Via Clinical Cancer Research

    Research

    Molecular alteration profiles characterize intraductal carcinoma of the prostate

    2026

    Via Cancer

    Research

    Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study

    2026

    Via Prostate Cancer and Prostatic Diseases

    Research

    Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy

    2026

    Via NPJ Precision Oncology

    Research

    Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial

    2026

    Via Clinical Cancer Research

    Research

    Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809)

    2026

    Via The Prostate

    Research

    Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing

    2026

    Via JCO Oncology Practice

    Research

    WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on Darolutamide

    2026

    Via European Urology Oncology

    Research

    Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs

    2026

    Via Future Oncology

    Research

    Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

    2026

    Via Journal of Clinical Oncology

    Research

    Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors

    2026

    Via Cancer Immunology Research

    Research

    Molecular landscape of prostate cancers with clival metastases

    2026

    Via The Oncologist

    Research

    Molecular Characterization of KLK2 RNA Expression in Prostate Cancer

    2026

    Via Clinical Cancer Research

    Research

    Landscape of somatic genetic alterations and PAM50 intrinsic subtypes in breast cancer associated with germline pathogenic variants in DNA-repair genes

    2026

    Via Journal of the National Cancer Institute

    Research

    Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)

    2026

    Via Prostate Cancer and Prostatic Diseases